221 related articles for article (PubMed ID: 11749830)
1. Down-regulation of MAO-B activity and imidazoline receptors in rat brain following chronic treatment of morphine.
Su RB; Li J; Li X; Qin BY
Acta Pharmacol Sin; 2001 Jul; 22(7):639-44. PubMed ID: 11749830
[TBL] [Abstract][Full Text] [Related]
2. High-affinity binding of beta-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain.
Miralles A; Esteban S; Sastre-Coll A; Moranta D; Asensio VJ; García-Sevilla JA
Eur J Pharmacol; 2005 Aug; 518(2-3):234-42. PubMed ID: 16061219
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
5. Effect of agmatine on long-term potentiation in morphine-treated rats.
Lu W; Dong HJ; Bi GH; Zhao YQ; Yang Z; Su RB; Li J
Pharmacol Biochem Behav; 2010 Aug; 96(2):125-9. PubMed ID: 20451544
[TBL] [Abstract][Full Text] [Related]
6. Influence of idazoxan on analgesia, tolerance, and physical dependence of morphine in mice and rats in vivo.
Su RB; Li J; Gao K; Pei G; Qin BY
Acta Pharmacol Sin; 2000 Nov; 21(11):1011-5. PubMed ID: 11501055
[TBL] [Abstract][Full Text] [Related]
7. Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine.
Li J; Li X; Pei G; Qin BY
Zhongguo Yao Li Xue Bao; 1999 Apr; 20(4):375-80. PubMed ID: 10452129
[TBL] [Abstract][Full Text] [Related]
8. I2-imidazoline binding sites: relationship with different monoamine oxidase domains and identification of histidine residues mediating ligand binding regulation by H+1.
Limon-Boulez I; Tesson F; Gargalidis-Moudanos C; Parini A
J Pharmacol Exp Ther; 1996 Feb; 276(2):359-64. PubMed ID: 8632297
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
10. Analgesic effect of agmatine and its enhancement on morphine analgesia in mice and rats.
Li J; Li X; Pei G; Qin BY
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):81-5. PubMed ID: 10437131
[TBL] [Abstract][Full Text] [Related]
11. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
12. Agmatine blocks morphine-evoked hyperthermia in rats.
Rawls SM; Amin M; Zisk J
Brain Res; 2007 May; 1147():89-94. PubMed ID: 17376409
[TBL] [Abstract][Full Text] [Related]
13. Determination of α(2)-adrenoceptor and imidazoline receptor involvement in augmentation of morphine and oxycodone analgesia by agmatine and BMS182874.
Bhalla S; Rapolaviciute V; Gulati A
Eur J Pharmacol; 2011 Jan; 651(1-3):109-21. PubMed ID: 21114998
[TBL] [Abstract][Full Text] [Related]
14. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
15. Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor.
Wu N; Su RB; Liu Y; Lu XQ; Zheng JQ; Cong B; Li J
Eur J Pharmacol; 2006 Oct; 548(1-3):21-8. PubMed ID: 16962578
[TBL] [Abstract][Full Text] [Related]
16. Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors.
Sánchez-Blázquez P; Boronat MA; Olmos G; García-Sevilla JA; Garzón J
Br J Pharmacol; 2000 May; 130(1):146-52. PubMed ID: 10781010
[TBL] [Abstract][Full Text] [Related]
17. Effect of agmatine on brain L-citrulline production during morphine withdrawal in rats: a microdialysis study in nucleus accumbens.
Yananli H; Gören MZ; Berkman K; Aricioğlu F
Brain Res; 2007 Feb; 1132(1):51-8. PubMed ID: 17182008
[TBL] [Abstract][Full Text] [Related]
18. Influence of agmatine in adaptation of cAMP signal transduction system of opiate receptors.
Li J; Li X; Pei G; Qin BY
Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):592-6. PubMed ID: 10678119
[TBL] [Abstract][Full Text] [Related]
19. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.
Olmos G; Miralles A; Barturen F; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1992 Mar; 260(3):1000-7. PubMed ID: 1545372
[TBL] [Abstract][Full Text] [Related]
20. Effects of agmatine on tolerance to and substance dependence on morphine in mice.
Li J; Li X; Pei G; Qin BY
Zhongguo Yao Li Xue Bao; 1999 Mar; 20(3):232-8. PubMed ID: 10452098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
